Clinical Trials

We have been performing phase 1 to 4 clinical trials in all areas of ophthalmology throughout Europe, North Africa, and North America since 1994.

At Iris Pharma, we have decades of experience in performing comprehensive clinical research and development in all areas of ophthalmology. This has allowed us to build a network of experienced investigative sites and scientists in each eye disease and condition to support efficient patient recruitment.

During the clinical development process, we take into account a drug or device’s future use and anticipate possible risks, to facilitate and accelerate New Drug Applications (NDA) and Marketing Authorization Applications (MAA).  


 KEY FIGURE: 125 clinical trials in ophthalmology performed